NO20022739L - Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)-2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on og nevroleptika for behandling eller forhindring av psykotiske lidelser - Google Patents

Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)-2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on og nevroleptika for behandling eller forhindring av psykotiske lidelser Download PDF

Info

Publication number: NO20022739L
Authority: NO; Norway
Prior art keywords: prevention; dioxino; neuroleptics; benzylamino; indol
Prior art date: 1999-12-10

Application number

NO20022739A

Other languages

English (en)

Other versions

NO20022739D0 (no

Inventor

Karen Lovell Marquis

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-10

Filing date

2002-06-07

Publication date

2002-06-07

2002-06-07 Application filed by Wyeth Corp filed Critical Wyeth Corp

2002-06-07 Publication of NO20022739D0 publication Critical patent/NO20022739D0/no

2002-06-07 Publication of NO20022739L publication Critical patent/NO20022739L/no

Links

208000028017 Psychotic disease Diseases 0.000 title description 3
230000002265 prevention Effects 0.000 title description 3
230000001225 therapeutic effect Effects 0.000 title description 2
DYJIKHYBKVODAC-ZDUSSCGKSA-N (2s)-2-[(benzylamino)methyl]-2,3,7,9-tetrahydro-[1,4]dioxino[2,3-e]indol-8-one Chemical compound C([C@H]1COC=2C=CC3=C(C=2O1)CC(N3)=O)NCC1=CC=CC=C1 DYJIKHYBKVODAC-ZDUSSCGKSA-N 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Description

Terapeutiske kombinasjoner nyttige for behandling eller forhindring av psykotiske lidelser, farmasøytiske preparater inneholdende nevnte kombinasjoner og anvendelse av dem for behandling eller forhindring av psykotiske lidelser er tilveiebragt.

NO20022739A 1999-12-10 2002-06-07 Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)-2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on og nevroleptika for behandling eller forhindring av psykotiske lidelser NO20022739L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US45860799A	1999-12-10	1999-12-10
PCT/US2000/033060 WO2001041750A2 (en)	1999-12-10	2000-12-07	Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics

Publications (2)

Publication Number	Publication Date
NO20022739D0 NO20022739D0 (no)	2002-06-07
NO20022739L true NO20022739L (no)	2002-06-07

Family

ID=23821437

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20022739A NO20022739L (no)	1999-12-10	2002-06-07	Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)-2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on og nevroleptika for behandling eller forhindring av psykotiske lidelser

Country Status (20)

Country	Link
EP (1)	EP1235570A2 (no)
JP (1)	JP5557409B2 (no)
KR (1)	KR100772854B1 (no)
CN (1)	CN1230164C (no)
AR (1)	AR026756A1 (no)
AU (1)	AU784211B2 (no)
BR (1)	BR0016168A (no)
CA (1)	CA2396351C (no)
CZ (1)	CZ20021880A3 (no)
EA (1)	EA005002B1 (no)
HK (1)	HK1045942A1 (no)
HU (1)	HUP0203309A3 (no)
IL (2)	IL149669A0 (no)
MX (1)	MXPA02005649A (no)
NO (1)	NO20022739L (no)
NZ (1)	NZ519381A (no)
PL (1)	PL355292A1 (no)
TW (1)	TWI222864B (no)
WO (1)	WO2001041750A2 (no)
ZA (1)	ZA200205484B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1874767A (zh)	2003-10-29	2006-12-06	惠氏公司	包含aplindore和其衍生物的缓释药物组合物
WO2006089053A2 (en)	2005-02-17	2006-08-24	Wyeth	Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
US20110059947A1 (en) *	2008-02-13	2011-03-10	Targacept, Inc.	Alpha 7 nicotinic agonists and antipsychotics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2987484B2 (ja) *	1995-03-16	1999-12-06	大塚製薬株式会社	カルボスチリル誘導体の製造方法
US5756532A (en) *	1995-11-06	1998-05-26	American Home Products Corporation	Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
GB9627005D0 (en) *	1996-12-27	1997-02-12	Knoll Ag	Therapeutic agents

2000
- 2000-12-07 KR KR1020027007286A patent/KR100772854B1/ko not_active IP Right Cessation
- 2000-12-07 CN CNB008169527A patent/CN1230164C/zh not_active Expired - Lifetime
- 2000-12-07 NZ NZ519381A patent/NZ519381A/en unknown
- 2000-12-07 HU HU0203309A patent/HUP0203309A3/hu unknown
- 2000-12-07 WO PCT/US2000/033060 patent/WO2001041750A2/en active IP Right Grant
- 2000-12-07 EA EA200200656A patent/EA005002B1/ru not_active IP Right Cessation
- 2000-12-07 BR BR0016168-3A patent/BR0016168A/pt not_active Application Discontinuation
- 2000-12-07 MX MXPA02005649A patent/MXPA02005649A/es active IP Right Grant
- 2000-12-07 CZ CZ20021880A patent/CZ20021880A3/cs unknown
- 2000-12-07 AU AU19490/01A patent/AU784211B2/en not_active Ceased
- 2000-12-07 PL PL00355292A patent/PL355292A1/xx not_active Application Discontinuation
- 2000-12-07 EP EP00982461A patent/EP1235570A2/en not_active Withdrawn
- 2000-12-07 JP JP2001543095A patent/JP5557409B2/ja not_active Expired - Lifetime
- 2000-12-07 CA CA002396351A patent/CA2396351C/en not_active Expired - Lifetime
- 2000-12-07 AR ARP000106504A patent/AR026756A1/es unknown
- 2000-12-07 IL IL14966900A patent/IL149669A0/xx active IP Right Grant
- 2000-12-08 TW TW089126071A patent/TWI222864B/zh not_active IP Right Cessation
2002
- 2002-05-15 IL IL149669A patent/IL149669A/en not_active IP Right Cessation
- 2002-06-07 NO NO20022739A patent/NO20022739L/no not_active Application Discontinuation
- 2002-07-09 ZA ZA200205484A patent/ZA200205484B/xx unknown
- 2002-10-09 HK HK02107378.5A patent/HK1045942A1/zh unknown

Also Published As

Publication number	Publication date
CZ20021880A3 (cs)	2002-08-14
IL149669A (en)	2006-06-11
PL355292A1 (en)	2004-04-05
JP5557409B2 (ja)	2014-07-23
NO20022739D0 (no)	2002-06-07
EP1235570A2 (en)	2002-09-04
IL149669A0 (en)	2002-11-10
NZ519381A (en)	2004-04-30
ZA200205484B (en)	2003-12-31
AU784211B2 (en)	2006-02-23
CA2396351C (en)	2009-11-10
KR20030016207A (ko)	2003-02-26
WO2001041750A3 (en)	2002-02-14
EA200200656A1 (ru)	2002-12-26
CN1409633A (zh)	2003-04-09
TWI222864B (en)	2004-11-01
WO2001041750A2 (en)	2001-06-14
MXPA02005649A (es)	2004-09-10
CA2396351A1 (en)	2001-06-14
HUP0203309A3 (en)	2004-12-28
CN1230164C (zh)	2005-12-07
HK1045942A1 (zh)	2002-12-20
AU1949001A (en)	2001-06-18
HUP0203309A2 (hu)	2003-01-28
AR026756A1 (es)	2003-02-26
BR0016168A (pt)	2002-08-20
JP2003516350A (ja)	2003-05-13
KR100772854B1 (ko)	2007-11-02
EA005002B1 (ru)	2004-10-28

Similar Documents

Publication	Publication Date	Title
NO996433L (no)	2000-02-14	Nye formuleringer av legemidler, fremgangsmåter for fremstilling derav og fremgangsmåter for anvendelse derav
HUP9700603A3 (en)	2001-08-28	Pharmaceutical preparation for the treatment of blood coagulation disorders
HUP9901807A3 (en)	2000-08-28	Heterocycle substituted n-acyl benzenesulfonamide derivatives, process for their preparation and their use as prodrug for the preparation of pharmaceutical compositions treating inflammation or inflammation-associated disorders
HUP9601566A2 (en)	1997-09-29	Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
IT1271462B (it)	1997-05-28	Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
NO963568D0 (no)	1996-08-27	Farmasöytisk preparat for behandling av blodkoagulasjonssykdommer, fremgangsmåter for fremstilling av dette og dets anvendelse
ITRM920412A1 (it)	1993-11-29	Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico.
AU2001266152A1 (en)	2002-01-02	Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
NO20022021D0 (no)	2002-04-29	Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler
CA2294921A1 (en)	1999-02-04	Levobupivacaine and its use
DE3875866D1 (de)	1992-12-17	Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie.
NO307510B1 (no)	2000-04-17	Bicykliske aromatiske forbindelser, deres anvendelse og farmasøytiske og kosmetiske preparater derav
EE9900162A (et)	1999-12-15	Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine
EP1440691A3 (en)	2004-08-25	Treatment of neurotic disorders
DE69200711T2 (de)	1995-03-30	Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung.
NO307930B1 (no)	2000-06-19	Benzo[f]kinolinoner, farmasøytisk formulering omfattende samme og anvendelse av samme for fremstilling av formulering for behandling
IT1290781B1 (it)	1998-12-10	Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
FR2756563B1 (fr)	1998-12-24	Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique
AR013264A1 (es)	2000-12-13	Derivados de 4-oxo-3,5-dihidro-4h-piridazino[4,5-b]indol-1-acetamida, medicamento y composicinn farmaceutica
NO20022739L (no)	2002-06-07	Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)-2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on og nevroleptika for behandling eller forhindring av psykotiske lidelser
WO1999020291A3 (en)	1999-07-08	Pharmaceutical grade ginkgo biloba
FR2765582B1 (fr)	1999-08-06	Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
AU2001235706A1 (en)	2001-08-27	Cosmetic or medicinal composition containing sesquiterpene lactone or the like for treating hair-growth related disorders, and preparation method
WO2000063348A3 (fr)	2000-12-28	Composition pharmaceutique comprenant des cellules nkt activees par des pim, et son utilisation en therapie
TR199901385T2 (xx)	1999-11-22	Piperidin t�revleri.

Legal Events

Date	Code	Title	Description
2010-07-05	FC2A	Withdrawal, rejection or dismissal of laid open patent application